Rocuronium: Difference between revisions
(→Common) |
|||
| Line 31: | Line 31: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: Variable by age, but anywhere from 30 minutes to 2 hours. | ||
*Metabolism: | *Metabolism: Metabolite is 17-desacetyl-rocuronium | ||
*Excretion: | *Excretion: Primary route is fecal. Renal also. | ||
*Mechanism of Action: | *Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Intermediate duration with dose dependant rapid to intermediate onset. Competes for cholinergic receptors at the motor end-plate. Acetylcholinesterase inhibitors like those found in organophosphates antagonize this action | ||
==See Also== | ==See Also== | ||
Revision as of 06:59, 3 November 2014
General
- Type: Neuromuscular blocker, Non-Depolarizing, Fast Onset, Intermediate Lasting
- Dosage Forms: IV
- Common Trade Names: Zemuron
Adult Dosing
RSI is 0.6 to 1.2 mg/kg IV (actual body weight)
Pediatric Dosing
RSI is 0.6 to 1.2 mg/kg IV (actual body weight)
Special Populations
- Pregnancy Rating: C
- Lactation: Infant risk cannot be ruled out
- Renal Dosing (half life approximately 1 hour longer if renal transplant patient)
- Adult
- Pediatric
- Hepatic Dosing (half life approximately 3 hours longer with liver dysfunction)
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Anaphylaxis
Common
Cardiovascular: HTN (0.1% to 2%). Hypotension (0.1% to 2%). Tachycardia (1% to 5.3%) Dermatologic: Pain at injection site Respiratory: Increased pulmonary vascular resistance (24%)
Pharmacology
- Half-life: Variable by age, but anywhere from 30 minutes to 2 hours.
- Metabolism: Metabolite is 17-desacetyl-rocuronium
- Excretion: Primary route is fecal. Renal also.
- Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Intermediate duration with dose dependant rapid to intermediate onset. Competes for cholinergic receptors at the motor end-plate. Acetylcholinesterase inhibitors like those found in organophosphates antagonize this action